Stock

Bright Minds Biosciences Inc. DRUG

$84.24-4.28%

All stocks Create account to unlock

Overview

DRUG market data

Price History

DRUG price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for DRUG. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

3 captured

HC Wainwright & Co. Reiterates Buy on Bright Minds Biosciences, Maintains $145 Price Target · Jun 1, 2026, 4:49 PM

Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline · May 21, 2026, 10:15 PM

Piper Sandler Maintains Overweight on Bright Minds Biosciences, Raises Price Target to $220 · May 20, 2026, 5:35 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock